[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-4-hydroxy-2-[[hydroxy-[hydroxy-[(3R)-3-hydroxy-2,2-dimethyl-3-[2-[2-(2-methylpropanoylsulfanyl)ethylcarbamoyl]ethylcarbamoyl]propoxy]phosphoryl]oxy-phosphoryl]oxymethyl]oxolan-3-yl]oxyphosphonic acid
[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-4-hydroxy-2-[[hydroxy-[hydroxy-[(3R)-3-hydroxy-2,2-dimethyl-3-[2-[2-(2-methylpropanoylsulfanyl)ethylcarbamoyl]ethylcarbamoyl]propoxy]phosphoryl]oxy-phosphoryl]oxymethyl]oxolan-3-yl]oxyphosphonic acid
CAS: 15621-60-0
Molecular Formula: C25H42N7O17P3S
[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-4-hydroxy-2-[[hydroxy-[hydroxy-[(3R)-3-hydroxy-2,2-dimethyl-3-[2-[2-(2-methylpropanoylsulfanyl)ethylcarbamoyl]ethylcarbamoyl]propoxy]phosphoryl]oxy-phosphoryl]oxymethyl]oxolan-3-yl]oxyphosphonic acid - Names and Identifiers
[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-4-hydroxy-2-[[hydroxy-[hydroxy-[(3R)-3-hydroxy-2,2-dimethyl-3-[2-[2-(2-methylpropanoylsulfanyl)ethylcarbamoyl]ethylcarbamoyl]propoxy]phosphoryl]oxy-phosphoryl]oxymethyl]oxolan-3-yl]oxyphosphonic acid - Physico-chemical Properties
| Molecular Formula | C25H42N7O17P3S |
| Molar Mass | 837.62 |
![[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-4-hydroxy-2-[[hydroxy-[hydroxy-[(3R)-3-hydroxy-2,2-dimethyl-3-[2-[2-(2-methylpropanoylsulfanyl)ethylcarbamoyl]ethylcarbamoyl]propoxy]phosphoryl]oxy-phosphoryl]oxymethyl]oxolan-3-yl]oxyphosphonic acid](http://res.chembk.com/assets/str/2d/1/15/15621-60-0.png)
Supplier List
Spot supply
Product Name: GPR17 antagonist 1 Visit Supplier Webpage Request for quotationCAS: 15621-60-0
Tel: 609-228-6898
Email: sales@medchemexpress.com
tech@medchemexpress.com
Mobile: 609-228-6898
Spot supply
Product Name: GPR17 antagonist 1 Visit Supplier Webpage Request for quotationCAS: 15621-60-0
Tel: 609-228-6898
Email: sales@medchemexpress.com
tech@medchemexpress.com
Mobile: 609-228-6898
View History
[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-4-hydroxy-2-[[hydroxy-[hydroxy-[(3R)-3-hydroxy-2,2-dimethyl-3-[2-[2-(2-methylpropanoylsulfanyl)ethylcarbamoyl]ethylcarbamoyl]propoxy]phosphoryl]oxy-phosphoryl]oxymethyl]oxolan-3-yl]oxyphosphonic acid
Phosphonic acid, [phenyl(phenylimino)methyl]-, diphenyl ester (9CI)
2-Benzhydryl-2-azaspiro[3.3]heptan-5-ol - B6694
Poly(oxy-1,2-ethanediy), alpha-phosphono-omega-(2,4,6-tris(1-phenylethyl)phenoxy), ca. 20 EO
AC-TYR(PO3H2)-GLU-N(C5H11)2
叔-丁基 4-氰基-4-(3-(环戊氧基)-4-甲氧苯基)哌啶-1-甲酸基酯
Emapalumab
17-Desacetyl Norgestimate-d6 (Major)
4-乙酰丁酸甲酯
4-甲基-2-(吡啶-4-基)噻唑-5-羧酸乙酯
Phosphonic acid, [phenyl(phenylimino)methyl]-, diphenyl ester (9CI)
2-Benzhydryl-2-azaspiro[3.3]heptan-5-ol - B6694
Poly(oxy-1,2-ethanediy), alpha-phosphono-omega-(2,4,6-tris(1-phenylethyl)phenoxy), ca. 20 EO
AC-TYR(PO3H2)-GLU-N(C5H11)2
叔-丁基 4-氰基-4-(3-(环戊氧基)-4-甲氧苯基)哌啶-1-甲酸基酯
Emapalumab
17-Desacetyl Norgestimate-d6 (Major)
4-乙酰丁酸甲酯
4-甲基-2-(吡啶-4-基)噻唑-5-羧酸乙酯